Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Circulation|October 17, 2001
Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteriesM B DeYoung, C Tom, D A DichekMethods in Molecular Biology (Clifton, N.J.)|January 1, 1997
Design of the hairpin ribozyme for targeting specific RNA sequencesA Hampel, M B DeYoung, S Galasinski, et al.Molecular Pharmacology|October 1, 1993
Coupling of expressed alpha 1B- and alpha 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specificD M Perez, M B DeYoung, R M GrahamDiabetes, Obesity & Metabolism|November 15, 2011
The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic reviewJ H Best, K Lavillotti, M B DeYoung, et al.The Journal of Biological Chemistry|November 22, 1996
Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivoG Dong, A H Schulick, M B DeYoung, et al.Diabetes, Obesity & Metabolism|July 11, 2012
GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependenceA R Meloni, M B DeYoung, C Lowe, et al.Human Gene Therapy|July 8, 1999
Optimizing vascular gene transfer of plasminogen activator inhibitor 1M B DeYoung, C Zamarron, A P Lin, et al.The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
kappa-Opioid receptor effects of butorphanol in rhesus monkeysJ A Vivian, M B DeYoung, T L Sumpter, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2010
Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjectsC Ellero, J Han, S Bhavsar, et al.Pageof 2